Romosozumab versus teriparatide and risk of all-cause mortality in patients with osteoporosis: a real-world propensity score-matched cohort study
| Title: | Romosozumab versus teriparatide and risk of all-cause mortality in patients with osteoporosis: a real-world propensity score-matched cohort study |
|---|---|
| Authors: | Tsai, Sung Huang LaurentAff1, Aff2, Aff3, Aff4, Aff7, Aff13, IDs0019802607968w_cor1; Chen, Yu HsuanAff5; Yang, Chi-YaAff6, Aff7; Lee, Ching-YuAff1, Aff2; Chen, Chia-HsienAff1, Aff2; Huang, Tsung-JenAff1, Aff2; Wu, Meng-HuangAff1, Aff2, Aff13; Huang, Hung-EnAff8, Aff9; James, Wei Cheng ChungAff10, Aff11, Aff12 |
| Source: | Osteoporosis International: With other metabolic bone diseases. :1-10 |
| Database: | Springer Nature Journals |